@article{a2a872124d6f4f90904adf9a3ccaf7cb,
title = "Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer (Cancer Chemotherapy and Pharmacology, (2018), 82, 3, (407-418), 10.1007/s00280-018-3623-7)",
abstract = "The original version of this article unfortunately contained a mistake. The co-authors{\textquoteright} names were incorrect.",
author = "Amita Patnaik and Michael Gordon and Frank Tsai and Papadopoulos, {Kyriakos P.} and Drew Rasco and Muralidhar Beeram and Siqing Fu and Filip Janku and Hynes, {Scott M.} and Gundala, {Sushma R.} and Willard, {Melinda D.} and Wei Zhang and Lin, {Aimee Bence} and David Hong",
note = "Publisher Copyright: {\textcopyright} 2018, Springer-Verlag GmbH Germany, part of Springer Nature.",
year = "2018",
month = sep,
day = "1",
doi = "10.1007/s00280-018-3641-5",
language = "English (US)",
volume = "82",
pages = "419",
journal = "Cancer chemotherapy and pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "3",
}